Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Enveric Biosciences, Inc.ENVB · Entity 8193 | Director | March 18, 2021 | April 02, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Enveric Biosciences, Inc.
Report date March 18, 2021 · Filed April 02, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,265 |
Reported balance
After 2021-03-18 transaction · row 1
1 source rowRow 1 · 2021-03-18 · Grant · Acquired 2,265 · Balance 2,265 F1: Represents restricted stock granted to the reporting person pursuant to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan (the "Plan"). Such shares vested in full on the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock granted to the reporting person pursuant to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan (the "Plan"). Such shares vested in full on the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 18, 2021 Filed Apr 2, 2021 21:26 UTC | Enveric Biosciences, Inc. ENVB · Entity 8193 | GrantCommon Stock | 2,265 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-007899 · ownership.xml · nonDerivative · entry 1 LIND DOUGLAS · CIK 0001181206 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,265 F1 · shares: Represents restricted stock granted to the reporting person pursuant to the Enveric Biosciences, Inc. 2020 Long-Term Incentive Plan (the "Plan"). Such shares vested in full on the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.